Catalyst Assets

Catalyst Assets LLC is a private life sciences holding company and intellectual property management firm based in Jackson, Wyoming. Founded in 2007 by Dr. Joseph A. Sorge, the founder and former CEO of Stratagene, the company was established to acquire and manage a specialized portfolio of molecular diagnostic assets and technologies following Stratagene's acquisition by Agilent Technologies. Operating primarily through its subsidiary, Decisive Diagnostics, Catalyst Assets focuses on the development and commercialization of advanced laboratory tools, including PCR-based diagnostic applications and genomic analysis platforms. The firm is actively involved in the strategic licensing and enforcement of its intellectual property, which includes significant patents in the fields of nucleic acid amplification and polymorphism identification. Catalyst Assets plays a key role in the diagnostics sector by bridging the gap between academic research and commercial diagnostic products.